David A. Hunstad

5.2k total citations
82 papers, 3.8k citations indexed

About

David A. Hunstad is a scholar working on Epidemiology, Molecular Biology and Endocrinology. According to data from OpenAlex, David A. Hunstad has authored 82 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 26 papers in Molecular Biology and 22 papers in Endocrinology. Recurrent topics in David A. Hunstad's work include Urinary Tract Infections Management (35 papers), Escherichia coli research studies (21 papers) and Urinary Bladder and Prostate Research (19 papers). David A. Hunstad is often cited by papers focused on Urinary Tract Infections Management (35 papers), Escherichia coli research studies (21 papers) and Urinary Bladder and Prostate Research (19 papers). David A. Hunstad collaborates with scholars based in United States, Egypt and France. David A. Hunstad's co-authors include Sheryl S. Justice, Scott J. Hultgren, Lisa K. McLellan, Lynette Cegelski, Teri N. Hreha, Jennifer A. Loughman, Patrick C. Seed, Kristin M. Tiemann, Stephanie A. Fritz and Patrick D. Olson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nano Letters.

In The Last Decade

David A. Hunstad

78 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Hunstad United States 33 1.4k 1.3k 856 543 430 82 3.8k
Glen C. Ulett Australia 43 2.4k 1.8× 1.4k 1.1× 1.3k 1.5× 508 0.9× 288 0.7× 134 5.0k
Chia‐Suei Hung United States 29 1.5k 1.1× 1.9k 1.5× 1.6k 1.8× 357 0.7× 462 1.1× 51 4.6k
Annelie Brauner Sweden 37 1.6k 1.2× 1.2k 1.0× 968 1.1× 352 0.6× 524 1.2× 170 4.9k
Jeffrey P. Henderson United States 37 814 0.6× 1.5k 1.1× 722 0.8× 543 1.0× 173 0.4× 79 3.9k
Karen Dodson United States 30 1.0k 0.7× 1.7k 1.3× 1.4k 1.7× 249 0.5× 301 0.7× 59 3.4k
Patrick C. Seed United States 34 2.1k 1.5× 3.2k 2.5× 1.1k 1.3× 432 0.8× 405 0.9× 103 6.1k
Jennifer N. Walker United States 18 2.3k 1.7× 1.2k 0.9× 1.1k 1.3× 312 0.6× 575 1.3× 28 4.2k
Kimberly A. Kline United States 53 1.2k 0.9× 3.8k 3.0× 531 0.6× 865 1.6× 253 0.6× 186 7.7k
Makrina Totsika Australia 36 1.3k 0.9× 2.0k 1.6× 1.8k 2.2× 389 0.7× 212 0.5× 114 4.7k
John D. Williams United Kingdom 35 1.1k 0.8× 722 0.6× 201 0.2× 577 1.1× 210 0.5× 153 3.9k

Countries citing papers authored by David A. Hunstad

Since Specialization
Citations

This map shows the geographic impact of David A. Hunstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Hunstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Hunstad more than expected).

Fields of papers citing papers by David A. Hunstad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Hunstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Hunstad. The network helps show where David A. Hunstad may publish in the future.

Co-authorship network of co-authors of David A. Hunstad

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Hunstad. A scholar is included among the top collaborators of David A. Hunstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Hunstad. David A. Hunstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ma, Hongming, et al.. (2025). LDL receptor–mediated endocytosis of Escherichia coli α-hemolysin mediates renal epithelial toxicity. Proceedings of the National Academy of Sciences. 122(24). e2505482122–e2505482122.
3.
Pinkner, Jerome S., Robert Potter, Maxwell I. Zimmerman, et al.. (2024). Conformational ensembles in Klebsiella pneumoniae FimH impact uropathogenesis. Proceedings of the National Academy of Sciences. 121(39). e2409655121–e2409655121. 7 indexed citations
4.
Godfred‐Cato, Shana, Amber Kunkel, Ami B. Shah, et al.. (2024). Long-term Health Outcomes After Hospital Discharge Among Children Hospitalized for MIS-C or COVID-19, September 29, 2021, to June 21, 2022. The Pediatric Infectious Disease Journal. 43(11). 1074–1082. 2 indexed citations
5.
Potter, Robert, Kailun Zhang, Meghan A. Wallace, et al.. (2023). Uncharacterized and lineage-specific accessory genes within the Proteus mirabilis pan-genome landscape. mSystems. 8(4). e0015923–e0015923. 5 indexed citations
6.
Hsiao, Hui‐Mien, Xuemin Chen, Amber Kunkel, et al.. (2023). Serologic responses to COVID-19 vaccination in children with history of multisystem inflammatory syndrome (MIS-C). Vaccine. 41(17). 2743–2748. 3 indexed citations
7.
Mariano, Lívia Lacerda, et al.. (2022). The impact of biological sex on diseases of the urinary tract. Mucosal Immunology. 15(5). 857–866. 59 indexed citations
8.
Yousaf, Anna R, Amber Kunkel, Joseph Y. Abrams, et al.. (2022). COVID-19 Vaccine Reactogenicity and Vaccine Attitudes Among Children and Parents/Guardians After Multisystem Inflammatory Syndrome in Children or COVID-19 Hospitalization: September 2021—May 2022. The Pediatric Infectious Disease Journal. 42(3). 252–259. 8 indexed citations
9.
Song, Yue, Mahmoud Elsabahy, Sarosh Khan, et al.. (2021). Morphologic Design of Silver-Bearing Sugar-Based Polymer Nanoparticles for Uroepithelial Cell Binding and Antimicrobial Delivery. Nano Letters. 21(12). 4990–4998. 34 indexed citations
10.
McLellan, Lisa K., Michael R. McAllaster, Arthur S. Kim, et al.. (2021). A host receptor enables type 1 pilus-mediated pathogenesis of Escherichia coli pyelonephritis. PLoS Pathogens. 17(1). e1009314–e1009314. 30 indexed citations
11.
Cho, Sangho, Gyu Seong Heo, Sarosh Khan, et al.. (2018). A Vinyl Ether-Functional Polycarbonate as a Template for Multiple Postpolymerization Modifications. Macromolecules. 51(9). 3233–3242. 14 indexed citations
12.
McLellan, Lisa K. & David A. Hunstad. (2016). Urinary Tract Infection: Pathogenesis and Outlook. Trends in Molecular Medicine. 22(11). 946–957. 262 indexed citations
13.
Olson, Patrick D., Keith A. Hruska, & David A. Hunstad. (2015). Androgens Enhance Male Urinary Tract Infection Severity in a New Model. Journal of the American Society of Nephrology. 27(6). 1625–1634. 61 indexed citations
14.
Danka, Elizabeth S. & David A. Hunstad. (2014). Cathelicidin Augments Epithelial Receptivity and Pathogenesis in ExperimentalEscherichia coliCystitis. The Journal of Infectious Diseases. 211(7). 1164–1173. 21 indexed citations
15.
McPherson, Christopher, B. Warner, David A. Hunstad, Alexis Elward, & Edward P. Acosta. (2012). Oseltamivir Dosing in Premature Infants. The Journal of Infectious Diseases. 206(6). 847–850. 5 indexed citations
16.
17.
Horvath, Dennis J., Birong Li, Santiago Partida‐Sánchez, et al.. (2010). Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes and Infection. 13(5). 426–437. 94 indexed citations
18.
Hunstad, David A., Sheryl S. Justice, Chia‐Suei Hung, Scott Lauer, & Scott J. Hultgren. (2005). Suppression of Bladder Epithelial Cytokine Responses by Uropathogenic Escherichia coli. Infection and Immunity. 73(7). 3999–4006. 118 indexed citations
19.
Justice, Sheryl S., David A. Hunstad, Jerome S. Pinkner, et al.. (2005). Periplasmic Peptidyl Prolyl cis-trans Isomerases Are Not Essential for Viability, but SurA Is Required for Pilus Biogenesis in Escherichia coli. Journal of Bacteriology. 187(22). 7680–7686. 119 indexed citations
20.
Hunstad, David A. & Jeffrey A. Norton. (1995). Management of pancreatic carcinoma. Surgical Oncology. 4(2). 61–74. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glen C. Ulett Breakdown of academic impact, for papers by Chia‐Suei Hung Breakdown of academic impact, for papers by Annelie Brauner Breakdown of academic impact, for papers by Jeffrey P. Henderson Breakdown of academic impact, for papers by Karen Dodson Breakdown of academic impact, for papers by Patrick C. Seed Breakdown of academic impact, for papers by Jennifer N. Walker Breakdown of academic impact, for papers by Kimberly A. Kline Breakdown of academic impact, for papers by Makrina Totsika Breakdown of academic impact, for papers by John D. Williams
Rankless by CCL
2026